Skip to content

13F-HR filed by Omega Fund Management, LLC

Omega Fund Management, LLC filed this 13F-HR for the quarter ended 2014-12-31, filed 2015-03-23, with 7 holding rows worth $217,389,000 by the sum of the rows.

Accession
0000950123-15-004059
Filed
2015-03-23
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2014

A holdings report, 7 entries on the cover page, a total value of $217,389,000,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $217,389,000 with VALUE read as thousands by filing date, 13F file number 028-16844. The quarter's positions are built on this report. The resolved quarter.

The cover page states a total of $217,389,000,000, about 1,000 times the sum of the rows, $217,389,000. The filer likely wrote its cover total in dollars and its rows in thousands. This page uses the sum of the rows.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
PARATEK PHARMACEUTICALS INC699374302Equity2,138,872$82,454,000thousands by filing date
JUNO THERAPEUTICS INC48205A109COM1,425,000$74,414,000thousands by filing date
FIBROGEN INC31572Q808COM972,175$26,579,000thousands by filing date
EGALET CORP28226B104COM2,645,558$15,053,000thousands by filing date
ACHAOGEN INC004449104COM656,899$8,573,000thousands by filing date
DICERNA PHARMACEUTICALS INC253031108COM468,471$7,716,000thousands by filing date
PROTEON THERAPEUTICS INC74371L109COM250,000$2,600,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-15-004059this filing2015-03-23acceptance time not in the bulk data set